Why the study?
Major advances in the prevention, diagnosis, and management of cardiovascular implantable electronic device infections have occurred since the 2010 scientific statement, necessitating an update.
This updated AHA scientific statement provides current clinical guidance on the prevention, diagnosis, and management of cardiovascular implantable electronic device infections.
No takes yet. Share an insight, caveat, or question.
Captured external expert commentary on this paper, strongest first. Original sources are linked where available.
“We want to keep devices that are not infected in the patient's body. If it's infected, we want to take it out. It's not one part that's taken out, it's the whole device, the entire system. And that comes with risk to the patient, morbidity as well as mortality. In addition to that, [there's] significant financial cost to the healthcare system.”
“These patients are usually older and have multiple comorbid conditions and deserve multispecialty care in larger-volume medical centers.”
Clinical clause: Synthesizes current best practices for CIED infection management.
Baddour et al. (2023) conducted a review in Cardiovascular implantable electronic device infection. This updated scientific statement from the American Heart Association highlights recent advances in the prevention, diagnosis, and management of cardiovascular implantable electronic device infections.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: